This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
11/25/15 - 3:59:54 PM ET (BATS BZX Real-time Price)
NVS Day's Range
NVS 52 Week Range
NVS Business Summary
Novartis AG researches, develops, manufactures, and markets a range of healthcare products worldwide.View NVS key stats
Novartis AG - NVS - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Novartis AG as a
Buy with a ratings score of B-.
Report Snippet: We rate NOVARTIS AG (NVS) a BUY. This is driven by several positive factors, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. We feel its strengths outweigh the fact that the company has had sub par growth in net income.